The United States Renal Data System (USRDS) — New Findings, Challenges and Opportunities

This activity will provide highlights of recent updates on descriptive epidemiology of kidney disease (ESRD and CKD) and the Transition of Care in CKD (TC-CKD) Special Study Center in the United States. This information presented from the USRDS 2015 Annual Data Report (ADR) will cover key topics such as incidence, prevalence, mortality, hospitalization and cost. Key findings from ongoing research being conducted at the USRDS Coordinating Center, especially in the area of vascular access practices and the role of primary care among ESRD patients will be discussed. Data from this ongoing USRDS Special Study will be presented with discussion regarding contemporary national trends in patterns of care at the end-of-life among patients with ESRD. 

Learning Objectives: 

After participation in this activity, learners will be better able to:

  • Discuss recent data trends and findings in kidney disease linked to improved patient outcomes
PLEASE NOTE: YOU MUST LOGIN OR CREATE AN ACCOUNT BEFORE ENROLLING IN THIS EDUCATIONAL ACTIVITY. 

Once you're logged in the "ADD TO CART" button can be found at the bottom of this webpage.

Target Audience

  • Physicians
  • Nurses
  • Dialysis Technicians
Accreditation/Designation of Credit Statements:

Physician

The National Kidney Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Kidney Foundation designates this enduring for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse and Dialysis Technician

The National Kidney Foundation is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.5 contact hours of continuing nursing education (includes 0.0 contact hours in the area of pharmacology).

Method of Participation:

Learners will review the materials on accreditation information, target audience, learning objectives, and disclosure information; participate in the entire self-study consisting of slides and audio; and complete the post-test (minimum score of 70% required; learners will only have 3 attempts to pass the post-test) and evaluation to successfully earn credit.  The estimated time for completion is 1.5 hours. 

Declaration of Disclosure:

It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.  

If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest Policy.

Unlabeled/Investigational Use:

During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.

Disclaimer:

The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments.  This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.

Course summary
Available credit: 
  • 1.50 ANCC Dialysis Technician Contact Hours
  • 1.50 ANCC Nurse Contact Hours
  • 1.50 Attendance
Course opens: 
10/19/2016
Course expires: 
10/19/2017
Cost:
$25.00
Rating: 
0
Faculty Disclosures:

Kamyar Kalantar Zadeh, MD, MPH, PhD, FNKF
Professor and Chief
University of California Irvine
Orange, CA
Disclosure: Consultant: Abbott, AbbVie, Alexion Pharmaceuticals, Inc., Amgen, American Society of Nephrology, AstraZeneca, AVEO Pharmaceuticals, Inc., Chugai Pharmaceutical Co., Ltd., DaVita Healthcare Partners, Inc., Fresenius Medical Care North America, Genentech, Haymarket Media, Hospira, Kabi, Keryx Biopharmaceuticals, Inc., National Institutes of Health (NIH), NKF, Relypsa, Inc., Resverlogix Corp., Sanofi-Aventis, Shire Pharmaceuticals Plc, Vifor Pharma, UpToDate, ZS Pharma;     
Speakers Bureau: Abbott, AbbVie, Alexion Pharmaceuticals, Inc., Amgen, ASN, AstraZeneca, AVEO Pharmaceuticals, Inc., Chugai Pharmaceutical Co., Ltd., DaVita Healthcare Partners, Inc., Fresenius Medical Care North America, Genentech, Haymarket Media, Hospira, Fresenius Kabi, Keryx Biopharmaceuticals, Inc., National Institutes of Health (NIH), NKF, Relypsa, Inc., Resverlogix Corp., Sanofi-Aventis, Shire Pharmaceuticals Plc, Vifor Pharma, UpToDate, ZS Pharma; 
Research Grants: Abbott, AbbVie, Alexion Pharmaceuticals, Inc., Amgen, ASN, AstraZeneca, AVEO Pharmaceuticals, Inc., Chugai Pharmaceutical Co., Ltd., DaVita Healthcare Partners, Inc., Fresenius Medical Care North America, Genentech, Haymarket Media, Hospira, Fresenus Kabi, Keryx Biopharmaceuticals, Inc., National Institutes of Health (NIH), NKF, Relypsa, Inc., Resverlogix Corp., Sanofi-Aventis, Shire Pharmaceuticals Plc, Vifor Pharma, UpToDate, ZS Pharma.

Rajiv Saran, MD, MRCP, MS
Professor of Medicine and Epidemiology
Florence E. Bingham Professor of Nephrology
University of Michigan
Ann Arbor, MI
Disclosure: Has no financial relationships with commercial interest(s).

Yoshio Hall, MD, MS 
Associate Professor
University of Washington
Seattle, WA
Disclosure: Has no financial relationships with commercial interest(s).

Planning Committee Disclosures:

Alan Kliger, MD
Sr. VP Medical Affairs, Chief Quality Officer
Yale New Haven Health System
New Haven, CT
Disclosure: Has no financial relationships with commercial interest(s).

Daniel Weiner, MD, MS, FNKF
Nephrologist
Tufts Medical Center
Boston, MA
Disclosure: Research Grants: Dialysis Clinic, Inc. (DCI), Nephrogenex,Inc., JANNX Medical Systems, Inc.

Dena Rifkin, MD, MS, FNKF
Nephrologist & Clinical Epidemiologist
VA San Diego
La Jolla, CA
Disclosure: Has no financial relationships with commercial interest(s).

Katherine H Houle, MSN, APRN, C-FNP, CNN-NP
Nephrology Nurse Practitioner
UP Health System
Marquette, MI 
Disclosure: Has no financial relationships with commercial interest(s).

Amy Proctor, RN
Regional Quality Manager
Fresenius Medical Care
Houston, TX
Disclosure: Has no financial relationships with commercial interest(s).

Nathalie Harden 
Director, CME
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Danielle Nathan
Professional Education Director
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).
 
Anna Okoniewski
CME/CE Activities Manager
National Kidney Foundation    
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Francis Arden Purvis, PA-C, BS, MSPAS
Physician Assistant
Transplant Nephrology
SSM Health Saint Louis University Hospital
Saint Louis, MO
Disclosure: Has no financial relationships with commercial interest(s)

Available Credit

  • 1.50 ANCC Dialysis Technician Contact Hours
  • 1.50 ANCC Nurse Contact Hours
  • 1.50 Attendance

Accreditation Period

Course opens: 
10/19/2016
Course expires: 
10/19/2017

Price

Cost:
$25.00
Please login or register for a PERC account to take this course.

Required Hardware/software

System requirements can be found here.

Contact Information:

For any questions concerning this activity, please send an email to CMEinfo@kidney.org or call NKF at 1-800-622-9010.

To view NKF privacy and confidentiality policy as it relates to CME/CE activity, please visit http://www.kidney.org/

For additional professional education resources, contact NKF at 1-800-622-9010 or visit https://www.kidney.org/professionals